Localized pleural malignant mesothelioma

Pathology International

Volumn 53, Issue 9, 2003, Pages 616-621

  Hirano, Hiroshi ^a,b   Takeda, Shinichi ^b   Sawabata, Yoshinori ^b   Okumura, Yoshitomo ^b   Maeda, Hajime ^b   Hanibuchi, Masaki ^b,c   Ito, Masami ^b   Nakagawa, Masaru ^b   Uematsu, Kunio ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TONEYAMA NATIONAL HOSPITAL   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Localized pleural malignant mesothelioma

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; MEDICAL EXAMINATION; METASTASIS; PATHOLOGY; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUMOR RECURRENCE; X RAY PICTURE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FATAL OUTCOME; HUMANS; MALE; MESOTHELIOMA; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PLEURAL NEOPLASMS; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0242491741     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01529.x     Document Type: Article

References (24)

1. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997; 30: 403-18.
2. Erkilic S, Sari I, Tuncozgur B. Localized pleural malignant mesothelioma. Pathol Int 2001; 51: 812-15.
3. Crotty TB, Myers JL, Katzenstein AA, Tazelaar HD, Swensen SJ, Churg A. Localized malignant mesothelioma: A clinicopathologic and flow cytometric study. Am J Surg Pathol 1994; 18: 357-63.
4. Okamura H, Kamei T, Mitsuno A, Hongo H, Sakuma N, Ishihara T. Localized malignant mesothelioma of the pleura. Pathol Int 2001; 51: 654-60.
5. Ojeda HF, Mech K, Hicken WJ. Localized malignant mesothelioma: A case report. Am Surgeon 1998; 64: 881-5.
6. Obers VJ, Leiman G, Girdwood RW, Spiro FI. Primary malignant pleural tumors (mesotheliomas) presenting as localized masses. Acta Cytol 1988; 32: 567-75.
7. Gotfried MH, Quan SF, Sobonya RE. Diffuse epithelial pleural mesothelioma presenting as a solitary lung mass. Chest 1983; 84: 99-101.
8. Biselli M, Mark EK, Dickersin GR. Solitary fibrous tumor of the pleura: Eight new cases and review of 360 cases in the literature. Cancer 1981; 47: 2678-89.
9. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13: 640-58.
10. Hanau CA, Miettinen M. Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995; 26: 440-49.
11. Okike N, Bernatz PE, Woolner LB, Minn R. Localized mesothelioma of the pleura: Benign and malignant variants. J Thorac Cardiovasc Surg 1978; 75: 363-72.
12. Dalton WT, Zolliker AS, McCaughey WT, Jacques J, Kannerstein M. Localized primary tumors of the pleura: An analysis of 40 cases. Cancer 1979; 44: 1465-75.
13. Zeren H, Moran CA, Suster S, Fishback NF, Kossa MN. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathological, immunohistochemical, and ultrastructural study of 25 cases. Hum Pathol 1995; 26: 474-80.
14. Mittinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 2001; 25: 610-17.
15. Corson JM, Weiss LM, Banks-Schlegel SP, Pinkus GS. Keratin proteins and carcinoembryonic antigen in synovial sarcomas: an immunohistochemical study of 24 cases. Hum Pathol 1984; 15: 615-21.
16. Tsujimoto M, Ueda T, Nakashima H, Hamada H, Ishiguro S, Aozasa K. Monophasic and biphasic synovial sarcoma. An immunohistochemical study. Acta Pathol Jpn 1987; 37: 597-604.
17. Humphrey PA, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. Hum Pathol 1988; 19: 155-65.
18. Ro JY, Chen JL, Lee JS, Sahin AA, Ordonez NG, Ayala AG. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer 1992; 69: 376-86.
19. Noguchi M, Nakajima T, Hirohashi S, Akiba T, Shimosato Y. Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewis, and anti-Tn antibodies. Hum Pathol 1989; 20: 53-7.
20. Skov BG, Lauritzen AF, Hirsch FR, Skov T, Nielsen HW. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology 1994; 25: 431-7.
21. Collins CL, Ordonez NG, Schaefer R et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992; 141: 827-33.
22. Dejmek A, Brockstedt U, Hjerpe A. Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma. APMIS 1997; 105: 889-94.
23. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
24. Hirano H, Tsuji M, Kizaki T et al. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki-67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study. Med Electron Microsc 2002; 35: 16-23.